Coenzyme Q10
Coenzyme Q10 carries electrons from complexes I and II to complex III in the inner mitochondrial membrane, and in its reduced form, ubiquinol, it acts as a lipid-soluble antioxidant. The body makes it through the mevalonate pathway, the same pathway statins block. It is poorly absorbed, and the clinical evidence is thinner than its popularity suggests.
This page contains affiliate links. Titrate earns a small commission when you purchase through them, at no cost to you. This does not affect our recommendations.
What It Does
CoQ10 synthesis branches off the cholesterol pathway downstream of HMG-CoA reductase, so statins lower plasma CoQ10. Part of that fall reflects lower LDL, which carries CoQ10 in the blood; whether statins meaningfully deplete muscle CoQ10 is inconsistent across studies. The muscle-symptom question has two meta-analyses pointing in opposite directions. One found no effect on statin-associated muscle pain (Banach 2015); a later one with twice as many trials found a reduction in pain scores without any change in creatine kinase (Qu 2018). The trials were small and short, and muscle pain is subjective and prone to placebo effects.
Heart failure has the most-cited trial. Q-SYMBIO randomized 420 patients with moderate to severe heart failure to 300 mg a day or placebo for two years and reported fewer major cardiovascular events (15% versus 26%) and lower mortality (Mortensen 2014). It missed its planned enrollment, its short-term primary endpoints were neutral, and it has not been replicated. Guidelines have not adopted it.
For migraine prevention, a 42-patient trial found 300 mg a day halved attack frequency in 48% of patients versus 14% on placebo (Sándor 2005). The 2012 American Academy of Neurology guideline rated CoQ10 possibly effective (Holland 2012). Primary CoQ10 deficiency, a rare group of genetic disorders, is the one setting where supplementation is clearly required.
Absorption is the practical obstacle. CoQ10 is a large, highly lipophilic molecule; uptake is slow and limited, peak plasma levels arrive about six hours after a dose, and absorption improves with dietary fat (Bhagavan 2006).
Forms and Bioavailability
Absorption ratings are broad tiers. Head-to-head human trials rarely support a finer ranking among well-absorbed forms.
| Form | Absorption | Typical dose | Cost | Labels |
|---|---|---|---|---|
| Ubiquinonecoenzyme Q10, CoQ10 (oxidized) | LowHighly lipophilic with a large molecular weight; absorption is slow and incomplete, improved by taking with fat and by solubilized or oil-based formulations. Reduced to ubiquinol during or after absorption. | 100-300 mg daily with a meal | Low | 393 |
| Ubiquinolreduced CoQ10, Kaneka QH | ModerateThe reduced form, which predominates in plasma. Some studies show higher plasma CoQ10 per mg than ubiquinone, especially in older adults; the body interconverts the two forms. | 100-200 mg daily with a meal | High | 382 |
Labels column: number of labels named as coenzyme Q10 products that list this form. A product can list more than one form, and some labels do not state a form at all.
Ubiquinone is the oxidized form and ubiquinol the reduced form. The intestine reduces ubiquinone during absorption, and more than 90% of CoQ10 in plasma circulates as ubiquinol whichever form is swallowed. In a 12-person comparison, 200 mg of ubiquinol raised plasma CoQ10 more than the same dose of ubiquinone (Langsjoen 2014). Formulation, meaning an oil-based softgel versus dry powder, affects absorption at least as much as redox state. Ubiquinol oxidizes on contact with air and is sold only in softgels.
Typical Dosing
Clinical trials have used 100-300 mg per day, taken with a meal containing fat.
Food sources: organ meats, beef, chicken, fatty fish, soybean oil, peanuts.
What to Look For
Check the milligrams per softgel and the form. Choose oil-suspended softgels over dry tablets or powder capsules, and take them with the largest meal of the day. Doses above about 100 mg absorb better split into two.
CoQ10 resembles vitamin K structurally, and case reports describe reduced warfarin effect; anyone on warfarin should have their INR checked after starting or stopping it.
Red flags: "statin support" combinations with 30 mg of CoQ10, dry tablets at a premium price, and ubiquinol marketed as several times more potent. Green flags: a stated form, 100-300 mg per day, and a softgel in an oil base.
Ubiquinone
The form used in Q-SYMBIO. In an oil-based softgel taken with food, it is the value choice.
What to look for: 100-200 mg oil-suspended softgels, taken with the largest meal and split if the daily dose exceeds 100 mg.
Find on iHerb Affiliate linkUbiquinol
Plasma levels ran higher in a small study, and the advantage shrinks when ubiquinone is taken with fat. Not worth double the price by default.
What to look for: Kaneka ubiquinol (Kaneka QH) in softgels, stored away from heat.
Find on iHerb Affiliate linkProducts on Titrate
2,978 of the 214,745 labels in the NIH Dietary Supplement Label Database list coenzyme Q10 as an active ingredient (1,334 on market). 1,556 are sold as coenzyme Q10 products by name.
Top on-market labels, ranked by label completeness and simplicity:
Coenzyme Q10 does not have its own search category yet. Each product above links to its full label in the NIH database.
Related Tools
References
NIH National Center for Complementary and Integrative Health. Coenzyme Q10.
Sándor PS, et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology. 2005;64(4):713-715.
Bhagavan HN, Chopra RK. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res. 2006;40(5):445-453.
Holland S, et al. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults. Neurology. 2012;78(17):1346-1353.
Mortensen SA, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail. 2014;2(6):641-649.
Langsjoen PH, Langsjoen AM. Comparison study of plasma coenzyme Q10 levels in healthy subjects supplemented with ubiquinol versus ubiquinone. Clin Pharmacol Drug Dev. 2014;3(1):13-17.
Banach M, et al. Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials. Mayo Clin Proc. 2015;90(1):24-34.
Qu H, et al. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2018;7(19):e009835.
Stay current.
Get updates when the evidence changes. No spam, no sales.